{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:44:38Z","timestamp":1778863478323,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd004418.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000}}],"reference-count":94,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004418.pub4","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T22:02:50Z","timestamp":1346796170000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults"],"prefix":"10.1002","author":[{"given":"Noa","family":"Eliakim-Raz","sequence":"first","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Robenshtok","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"},{"name":"Ramat Aviv and Endocrinology and Metabolism Institute; Sackler School of Medicine, Tel Aviv University; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphna","family":"Shefet","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Gafter-Gvili","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liat","family":"Vidal","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine; Infectious Diseases Unit; Tel Aviv University Tel Aviv Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD004418.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1086\/516366","article-title":"Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults","volume":"26","author":"Aubier","year":"1998","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004418.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF02310353","article-title":"Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia","volume":"14","author":"Bohte","year":"1995","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004418.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.36.4.833","article-title":"Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia","volume":"36","author":"Carbon","year":"1992","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"52","key":"10.1002\/14651858.CD004418.pub4-BIB0004|cit4","first-page":"1913","article-title":"Effect and tolerance of ofloxacin in bronchopulmonary infections in comparison with amoxicillin","volume":"119","author":"Chuard","year":"1989","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"3","key":"10.1002\/14651858.CD004418.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0924-8579(00)00344-7","article-title":"An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem\/cilastatin in the intravenous treatment of hospitalised patients with pneumonia","volume":"17","author":"Feldman","year":"2001","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"26","key":"10.1002\/14651858.CD004418.pub4-BIB0006|cit6","first-page":"1240","article-title":"Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin","volume":"15","author":"Fourrier","year":"1986","journal-title":"La Presse Medicale"},{"issue":"11","key":"10.1002\/14651858.CD004418.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF01700406","article-title":"Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia","volume":"16","author":"Genn\u00e9","year":"1997","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"Supp D","key":"10.1002\/14651858.CD004418.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/18.Supplement_D.133","article-title":"Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin","volume":"18","author":"Gleadhill","year":"1986","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0009|cit9","unstructured":"Hatipoglu ON Uysal S Altiay G Sut N Tabakoglu E The effect of addition of macrolide to a beta-lactam antibiotic on treatment success in patients with moderately severe community acquired pneumonia (Abstract) Proceedings of the European Respiratory Society Annual Congress; 2010 September 18-22; Barcelona, Spain 2010"},{"issue":"10","key":"10.1002\/14651858.CD004418.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1532-5415.1991.tb04044.x","article-title":"A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections","volume":"39","author":"Hirata-Dulas","year":"1991","journal-title":"Journal of the American Geriatrics Society"},{"issue":"5","key":"10.1002\/14651858.CD004418.pub4-BIB0011|cit11","article-title":"Observation of the therapeutic effects of gatifloxacin on community acquired pneumonia","author":"Hong-yun","year":"2007","journal-title":"Chinese Journal of Antibiotics"},{"issue":"15","key":"10.1002\/14651858.CD004418.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0025-7753(00)71625-3","article-title":"Oral levofloxacin versus intravenous ceftriaxone and amoxicillin\/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization","volume":"115","author":"Kalbermatter","year":"2000","journal-title":"Medicina Clinica"},{"issue":"3","key":"10.1002\/14651858.CD004418.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.96.3.528","article-title":"Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections","volume":"96","author":"Khan","year":"1989","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD004418.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.11150\/kansenshogakuzasshi1970.58.525","article-title":"Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections","volume":"58","author":"Kobayashi","year":"1984","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0015|cit15","first-page":"32","article-title":"Clinical phase III comparative study of intravenous levofloxacin and ceftriaxone in community-acquired pneumonia treatment","volume":"59","author":"Kohno","year":"2011","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD004418.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.rmed.2004.04.007","article-title":"Gemifloxacin once daily for 7 days compared to amoxicillin\/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin","volume":"98","author":"Leophonte","year":"2004","journal-title":"Respiratory Medicine"},{"issue":"12","key":"10.1002\/14651858.CD004418.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1183\/09031936.95.08121999","article-title":"Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin","volume":"8","author":"Lode","year":"1995","journal-title":"European Respiratory Journal"},{"issue":"10","key":"10.1002\/14651858.CD004418.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.11150\/kansenshogakuzasshi1970.58.1083","article-title":"Comparative study of the effectiveness of enoxacin and amoxicillin in bacterial pneumonia by a double blind method","volume":"58","author":"Miki","year":"1984","journal-title":"Kansenshogaku Zasshi"},{"issue":"4","key":"10.1002\/14651858.CD004418.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00365549850160710","article-title":"A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia","volume":"30","author":"Norrby","year":"1998","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004418.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9343(88)80336-X","article-title":"Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin","volume":"85","author":"Peterson","year":"1988","journal-title":"American Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004418.pub4-BIB0021|cit21","first-page":"387","article-title":"A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial","volume":"39","author":"Jardim","year":"2003","journal-title":"Archives de Bronchoneumologia"},{"issue":"1","key":"10.1002\/14651858.CD004418.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.119.1.185","article-title":"Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults","volume":"119","author":"Petitpretz","year":"2001","journal-title":"Chest"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0023|cit23","first-page":"39","article-title":"Efficacy of the teicoplanin-ciprofloxacin combination in high risk community acquired pneumonia: Comparison to ceftriaxone in a multicenter study","volume":"31","author":"Allegra","year":"1995","journal-title":"Internista"},{"issue":"Supp 18","key":"10.1002\/14651858.CD004418.pub4-BIB0024|cit24","first-page":"170","article-title":"The teicoplanin-ciprofloxacin combination versus ceftriaxone in community acquired pneumonia of elderly and patients with underlying diseases","volume":"7","author":"Montemurro","year":"1993","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD004418.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00044011-199714050-00001","article-title":"Efficacy and tolerability of teicoplanin-ciprofloxacin combination in severe community-acquired pneumonia. Comparison with ceftriaxone in a multicentre Italian study","volume":"14","author":"Rizzato","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD004418.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1179\/joc.2002.14.6.609","article-title":"Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy","volume":"14","author":"Romanelli","year":"2002","journal-title":"Journal of Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD004418.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01691581","article-title":"Trovafloxacin versus high-dose amoxicillin (1g three times daily) in the treatment of community-acquired bacterial pneumonia","volume":"17","author":"Tremolieres","year":"1998","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"8-9","key":"10.1002\/14651858.CD004418.pub4-BIB0028|cit28","first-page":"503","article-title":"Efficacy and safety of pristinamycin vs amoxicillin in community acquired pneumonia in adults","volume":"53","author":"Tremolieres","year":"2005","journal-title":"Pathologie-biologie (Paris)"},{"issue":"Suppl B","key":"10.1002\/14651858.CD004418.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/26.suppl_B.111","article-title":"Comparison of pefloxacin with ceftazidime in severe bronchopulmonary infections","volume":"26","author":"Vanderdonckt","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supp C","key":"10.1002\/14651858.CD004418.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/28.suppl_C.81","article-title":"The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia","volume":"28","author":"Vogel","year":"1991","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004418.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01962179","article-title":"Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia","volume":"7","author":"Zeluff","year":"1988","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004418.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archinte.159.3.266","article-title":"Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia","volume":"159","author":"Ailani","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl A","key":"10.1002\/14651858.CD004418.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/37.suppl_A.73","article-title":"Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies","volume":"37","author":"Aubier","year":"1996","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD004418.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10096-007-0307-3","article-title":"Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia","volume":"26","author":"Chokshi","year":"2007","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004418.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0149-2918(97)80047-1","article-title":"Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study","volume":"19","author":"Donowitz","year":"1997","journal-title":"Clinical Therapeutics"},{"issue":"5A","key":"10.1002\/14651858.CD004418.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0002-9343(89)90050-8","article-title":"IV\/oral ciprofloxacin vs ceftazidime in the treatment of serious infections","volume":"87","author":"Fass","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004418.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.41.9.1965","article-title":"A multicenter, randomized study comparing the efficacy and safety of intravenous and\/or oral levofloxacin versus ceftriaxone and\/or cefuroxime axetil in treatment of adults with community-acquired pneumonia","volume":"41","author":"File","year":"1997","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD004418.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/AAC.38.3.547","article-title":"Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin","volume":"38","author":"Fink","year":"1994","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD004418.pub4-BIB0039|cit39","first-page":"131","article-title":"Clarithromycin versus cefaclor in lower respiratory tract infections","volume":"18","author":"Fong","year":"1995","journal-title":"Clinical and Investigative Medicine. M\u00e9decine Clinique et Experimentale"},{"issue":"12","key":"10.1002\/14651858.CD004418.pub4-BIB0040|cit40","first-page":"609","article-title":"Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalisation","volume":"19","author":"Geijo Martinez","year":"2002","journal-title":"Anales de Medicina Interna"},{"issue":"6","key":"10.1002\/14651858.CD004418.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s15010-002-2096-z","article-title":"Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia","volume":"30","author":"Hagberg","year":"2002","journal-title":"Infection"},{"issue":"Suppl E","key":"10.1002\/14651858.CD004418.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jac\/31.suppl_E.147","article-title":"A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections","volume":"31","author":"Hoepelman","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004418.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jemermed.2004.02.023","article-title":"Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy","volume":"27","author":"Katz","year":"2004","journal-title":"Journal of Emergency Medicine"},{"issue":"Suppl D","key":"10.1002\/14651858.CD004418.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/26.suppl_D.83","article-title":"A comparative study of ofloxacin and amoxycillin\/clavulanate in hospitalized patients with lower respiratory tract infections","volume":"26","author":"Khajotia","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD004418.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/BF01975846","article-title":"Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia","volume":"10","author":"Kinasewitz","year":"1991","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"Supp A","key":"10.1002\/14651858.CD004418.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/43.suppl_1.117","article-title":"Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy","volume":"43","author":"Krumpe","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD004418.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1179\/joc.2005.17.6.636","article-title":"Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study","volume":"17","author":"Kuzman","year":"2005","journal-title":"Journal of Chemotherapy"},{"issue":"36","key":"10.1002\/14651858.CD004418.pub4-BIB0048|cit48","first-page":"1975","article-title":"Levofloxacin in the treatment of community-acquired pneumococcal pneumonia","volume":"28","author":"Leophonte","year":"1999","journal-title":"La Presse Medicale"},{"issue":"5A","key":"10.1002\/14651858.CD004418.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-9343(89)90049-1","article-title":"Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections","volume":"87","author":"Levine","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD004418.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/AAC.31.10.1491","article-title":"Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections","volume":"31","author":"Lode","year":"1987","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Suppl","key":"10.1002\/14651858.CD004418.pub4-BIB0051|cit51","first-page":"50","article-title":"Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections","volume":"68","author":"Lode","year":"1990","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004418.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1469-0691.1998.tb00376.x","article-title":"Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumonia","volume":"4","author":"Lode","year":"1998","journal-title":"Clinical Microbiology and Infection"},{"issue":"6","key":"10.1002\/14651858.CD004418.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1469-0691.2004.00875.x","article-title":"Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia","volume":"10","author":"Lode","year":"2004","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"10.1002\/14651858.CD004418.pub4-BIB0054|cit54","first-page":"90","article-title":"Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia","volume":"8","author":"Mendonca","year":"2004","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004418.pub4-BIB0055|cit55","first-page":"34","article-title":"Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia","volume":"39","author":"Mouton","year":"1991","journal-title":"Pathologie-Biologie"},{"issue":"Supp A","key":"10.1002\/14651858.CD004418.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/40.suppl_1.73","article-title":"Randomized, double blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia","volume":"40","author":"O'Doherty","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004418.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s15010-007-7043-6","article-title":"Moxifloxacin vs ampicillin\/sulbactam in aspiration pneumonia and primary lung abscess","volume":"36","author":"Ott","year":"2008","journal-title":"Infection"},{"issue":"5A","key":"10.1002\/14651858.CD004418.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1016\/0002-9343(89)90055-7","article-title":"Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections","volume":"87","author":"Peacock","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004418.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/AAC.40.5.1175","article-title":"Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization","volume":"40","author":"Plouffe","year":"1996","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD004418.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijantimicag.2004.01.011","article-title":"Azithromycin versus comparative therapy for the treatment of community acquired pneumonia","volume":"24","author":"Rahav","year":"2004","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"Supp 2","key":"10.1002\/14651858.CD004418.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2165\/00003495-199500492-00127","article-title":"Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients","volume":"49","author":"Siami","year":"1995","journal-title":"Drugs"},{"issue":"5A","key":"10.1002\/14651858.CD004418.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"202S","DOI":"10.1016\/0002-9343(89)90059-4","article-title":"Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding","volume":"87","author":"Sifuentes-Osornio","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"Supp 2","key":"10.1002\/14651858.CD004418.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00003495-199500492-00128","article-title":"Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem\/cilastatin","volume":"49","author":"Snydman","year":"1995","journal-title":"Drugs"},{"issue":"6C","key":"10.1002\/14651858.CD004418.pub4-BIB0064|cit64","first-page":"52","article-title":"Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin","volume":"87","author":"Stocks","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004418.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diagmicrobio.2007.07.006","article-title":"Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with\/without a macrolide for the treatment of hospitalized patients with community-acquired pneumonia","volume":"60","author":"Bhavnani","year":"2008","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"1","key":"10.1002\/14651858.CD004418.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.03.00045202","article-title":"Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia","volume":"21","author":"Torres","year":"2003","journal-title":"European Respiratory Journal"},{"issue":"Supp 5A","key":"10.1002\/14651858.CD004418.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1016\/0002-9343(89)90037-5","article-title":"Randomized study of intravenous\/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections","volume":"87","author":"Trenholme","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD004418.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/498149","article-title":"Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy","volume":"41","author":"Welte","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"4A","key":"10.1002\/14651858.CD004418.pub4-BIB0069|cit69","first-page":"164","article-title":"Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections","volume":"82","author":"Wollschlager","year":"1987","journal-title":"American Journal of Medicine"},{"issue":"Suppl 4:IV","key":"10.1002\/14651858.CD004418.pub4-BIB0070|cit70","first-page":"1","article-title":"BTS guidelines for the management of community acquired pneumonia in adults","volume":"56","author":"British Thoracic Society","year":"2001","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0071|cit71","first-page":"717","article-title":"Acute Pneumonia","volume-title":"Principles and Practice of Infectious Diseases","volume":"1","author":"Donowitz","year":"2000"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0072|cit72","unstructured":"FDA Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf (accessed May 2010) (accessed May 2010)"},{"issue":"4","key":"10.1002\/14651858.CD004418.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/00365540500264050","article-title":"Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Hedlund","year":"2005","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0075|cit75","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration Available from www.cochrane-handbook.org 2011"},{"issue":"21","key":"10.1002\/14651858.CD004418.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1001\/jama.260.21.3159","article-title":"A clinical assessment of MedisGroups","volume":"260","author":"Iezzoni","year":"1988","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/46.6.973","article-title":"Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo","volume":"46","author":"Johansen","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0078|cit78","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0079|cit79","first-page":"1475","article-title":"Pneumonia, including necrotizing pulmonary infections (lung abscess)","volume-title":"Harrison's Principles of Internal Medicine","volume":"2","author":"Levison","year":"2001"},{"issue":"5","key":"10.1002\/14651858.CD004418.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004418.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"issue":"9560","key":"10.1002\/14651858.CD004418.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society","volume":"31","author":"Mandell","year":"2000","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004418.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"7489","key":"10.1002\/14651858.CD004418.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bmj.38334.591586.82","article-title":"Effectiveness of beta-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis","volume":"330","author":"Mills","year":"2005","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD004418.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004418.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkg413","article-title":"How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review","volume":"52","author":"Oosterheert","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0088|cit88","unstructured":"Paul M Nielsen AD Gafter-Gvili A Tacconelli E Andreassen S Almanasreh N The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis European Respiratory Journal"},{"issue":"16","key":"10.1002\/14651858.CD004418.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJMp078032","article-title":"The FDA and the case of Ketek","volume":"356","author":"Ross","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"16","key":"10.1002\/14651858.CD004418.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMc076135","article-title":"Ketek - the FDA perspective","volume":"356","author":"Soreth","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004418.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1183\/09031936.05.00055705","article-title":"Guidelines for the management of adult lower respiratory tract infections","volume":"26","author":"Woodhead","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD004418.pub4-BIB0092|cit92","first-page":"1","article-title":"Guidelines for the management of adult lower respiratory tract infections","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clinical Microbiology infections"},{"issue":"1","key":"10.1002\/14651858.CD004418.pub4-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004418.pub3","article-title":"Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults","author":"Robenshtok","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004418.pub4-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004418.pub3","article-title":"Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults","author":"Shefet","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004418.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:34:56Z","timestamp":1628544896000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004418.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Acute Respiratory Infections Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":94,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004418.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}